First Command Advisory Services’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
First Command Advisory Services's VKTX Position: Q2 2026 in Review
First Command Advisory Services sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 90 shares — an estimated $2.93K sold.
First Command Advisory Services first reported a position in VKTX in Q1 2026 and held it in 1 quarter. The position peaked at $2.93K in Q1 2026. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- First Command Advisory Services reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
- First Command Advisory Services sold 90 Viking Therapeutics shares in Q2 2026, an estimated $2.93K.
- First Command Advisory Services first reported a position in Viking Therapeutics in Q1 2026 and held it in 1 quarter.
- First Command Advisory Services's Viking Therapeutics position peaked at $2.93K in Q1 2026.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.